Cargando…

Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?

Detalles Bibliográficos
Autores principales: Remon, Jordi, Besse, Benjamin, Soria, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397905/
https://www.ncbi.nlm.nih.gov/pubmed/28427399
http://dx.doi.org/10.1186/s12916-017-0857-x
_version_ 1783230361803685888
author Remon, Jordi
Besse, Benjamin
Soria, Jean-Charles
author_facet Remon, Jordi
Besse, Benjamin
Soria, Jean-Charles
author_sort Remon, Jordi
collection PubMed
description
format Online
Article
Text
id pubmed-5397905
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53979052017-04-21 Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer? Remon, Jordi Besse, Benjamin Soria, Jean-Charles BMC Med Erratum BioMed Central 2017-04-20 /pmc/articles/PMC5397905/ /pubmed/28427399 http://dx.doi.org/10.1186/s12916-017-0857-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Erratum
Remon, Jordi
Besse, Benjamin
Soria, Jean-Charles
Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title_full Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title_fullStr Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title_full_unstemmed Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title_short Erratum to: Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
title_sort erratum to: successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397905/
https://www.ncbi.nlm.nih.gov/pubmed/28427399
http://dx.doi.org/10.1186/s12916-017-0857-x
work_keys_str_mv AT remonjordi erratumtosuccessesandfailureswhatdidwelearnfromrecentfirstlinetreatmentimmunotherapytrialsinnonsmallcelllungcancer
AT bessebenjamin erratumtosuccessesandfailureswhatdidwelearnfromrecentfirstlinetreatmentimmunotherapytrialsinnonsmallcelllungcancer
AT soriajeancharles erratumtosuccessesandfailureswhatdidwelearnfromrecentfirstlinetreatmentimmunotherapytrialsinnonsmallcelllungcancer